Chamberlain A C
Proc R Soc Lond B Biol Sci. 1985 Apr 22;224(1235):149-82. doi: 10.1098/rspb.1985.0027.
To predict the response of blood lead to airborne and dietary lead requires knowledge of the rate of uptake of lead into the body from lung and gut, its subsequent partitioning between compartments, the stay time in those compartments, and its redistribution or excretion. Tracer studies with volunteers have shown no differences in systemic distribution of inorganic lead between tissues whether it is taken by inhalation, ingestion or injection. Lead is rapidly transferred from plasma to red cells, and there is slower movement thence into liver and other soft tissues, to bone, and to excreta. Work at Harwell and elsewhere with 203Pb has shown that the initial rapid distribution leaves rather over half the assimilated lead attached to red cells. The result is remarkably consistent, and applies also to dogs and baboons. The renal clearance (Vu) (ratio of U to CB, or daily urinary output expressed as mass of blood having the same lead content), and also the endogenous faecal clearance excretion rate (Vf), have been measured on human subjects with 203Pb. The results are consistent with Vu, as measured with stable lead, with many results giving Vu about 0.1 kg d-1. However, there is evidence that Vu increases when CB is elevated above the normal. This may explain the nonlinear relation between uptake of lead and the corresponding CB, which has been observed in humans exposed to environmental lead. Vf is about half Vu, and a similar result applies to calcium. The clearance rate Va of 203Pb from blood to bone has been measured, and a variety of human and animal data in the literature has been reviewed to support this result. Combined with bone turnover rates (from data on 90Sr), the postulated inputs to bone give estimates of skeletal burdens which agree with post-mortem results. The results are combined in a compartment model. The retention of lead aerosol in the lung, and uptake from the gut are then considered, with use made of radioactive tracer (203Pb), stable isotopic tracer (204Pb) and total lead measurements. Here there is great diversity of results. Particle size affects the fractional lung retention and the site of retention, which in turn affects the fractional uptake to blood. Presence or absence of food in the stomach when lead is ingested greatly affects the fractional gut uptake. Finally, a limited selection of results of volunteer exposures to stable lead in air or diet are reviewed.(ABSTRACT TRUNCATED AT 400 WORDS)
要预测血铅对空气中铅及膳食中铅的反应,需要了解铅从肺和肠道进入人体的摄取速率、其在各隔室间随后的分配情况、在这些隔室中的停留时间以及其再分布或排泄情况。对志愿者进行的示踪研究表明,无论无机铅是通过吸入、摄入还是注射进入人体,各组织间的全身分布并无差异。铅迅速从血浆转移至红细胞,随后进入肝脏和其他软组织、骨骼及排泄物的速度则较慢。哈韦尔及其他地方对203Pb的研究表明,最初的快速分布使超过一半的同化铅附着在红细胞上。结果非常一致,且同样适用于狗和狒狒。已对人体受试者用203Pb测量了肾清除率(Vu)(尿中铅浓度与血中铅浓度之比,或以含相同铅含量的血液质量表示的每日尿量)以及内源性粪便清除排泄率(Vf)。结果与用稳定铅测量的Vu一致,许多结果显示Vu约为0.1 kg/d。然而,有证据表明当血铅浓度高于正常水平时Vu会增加。这可能解释了在接触环境铅的人群中观察到的铅摄取与相应血铅浓度之间的非线性关系。Vf约为Vu的一半,钙的情况也类似。已测量了203Pb从血液到骨骼的清除率Va,并对文献中的各种人类和动物数据进行了综述以支持这一结果。结合骨转换率(来自90Sr的数据),假定进入骨骼的铅量得出的骨骼负荷估计值与尸检结果相符。这些结果被整合到一个隔室模型中。然后利用放射性示踪剂(203Pb)、稳定同位素示踪剂(204Pb)和总铅测量数据,考虑铅气溶胶在肺中的滞留以及从肠道的摄取情况。这里的结果差异很大。颗粒大小会影响肺中滞留分数和滞留部位,进而影响进入血液的摄取分数。摄入铅时胃中是否有食物会极大地影响肠道摄取分数。最后,对志愿者暴露于空气中或膳食中的稳定铅的有限结果进行了综述。(摘要截取自400字)